Jameel Health, Jameel Corporation, and Yagami Sign Strategic Partnership Memorandum

Jameel Health FZE (Headquarters: Dubai, United Arab Emirates), Jameel Corporation (Headquarters: Chuo-ku, Tokyo, Japan), and Yagami Co., Ltd. (Headquarters: Naka-ku, Nagoya, Japan) have signed a Memorandum of Understanding for strategic partnership on August 2, 2024.

The MoU aims to explore and assess the feasibility of market research, product marketing, and distribution frameworks in the MENAT (Middle East, North Africa, and Turkey) region, India, and Japan. The objective is to establish an optimal business model that leverages the unique strengths and capabilities of each partner company.

This collaboration marks a significant first step for Jameel Health, Jameel Corporation, and Yagami in creating new business opportunities in the global market. Through this strategic partnership, the three companies aim to combine their strengths, deliver innovative solutions, and strive to contribute to the health and well-being of people around the world.

Leadership Comments on the Strategic Partnership:

Akram Bouchenaki, CEO of Jameel Health, stated: “We are confident that the synergy created by combining Yagami’s extensive 150-year history and its strong network of reputable Japanese manufacturers and medical institutions with Abdul Latif Jameel’s well-established distribution channels and network in the MENAT region, built over 75 years, will be highly impactful. We are honored to partner with Yagami in this important endeavor“

Koji Nagata, President & CEO of Jameel Corporation , commented: “We are very pleased to collaborate with Yagami. Through this initiative, we look forward to contributing to Japanese economy and the health of people around the world by introducing  Japanese products into markets such as the Middle East, Africa, and India.

Atsushi Araki, President of Yagami, remarked: “We are truly honored to collaborate with Abdul Latif Jameel. By leveraging Yagami’s strengths in networking with manufacturers and medical institutions, we aim to contribute to the health and well-being of people globally. We will start by introducing Japanese products in the MENAT and Indian regions, and further expand by bringing new overseas solutions into the domestic market in Japan, together with the Abdul Latif Jameel.”

About Jameel Health:

Jameel Health,part of Abdul Latif Jameel, was founded in 2020 with the aim of responding to one of the greatest problems of today’s global society – the disparity in access to modern medical care – through investments and partnerships that empower individuals and enable communities to prosper. Jameel Health’s focus is on accelerating access to modern medical care for existing solutions in markets that need it the most and investing in future MedTech advancements. It is uniquely positioned as a trusted partner in realizing major innovations and opportunities in the healthcare world. For further information, visit: : https://jameelhealth.com and our brand video here.

Media Contact: Email b.alkhatib@alj.ae or telephone: +971 55 5774646 (GMT +4 hours UAE).

Copyright Notice and Disclaimer © Meddist Company Ltd. (Jameel Health).  All rights fully reserved.  The Abdul Latif Jameel name, and the Abdul Latif Jameel logotype and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited. The term “Abdul Latif Jameel” refers broadly to several distinct, separate and independent legal entities. Abdul Latif Jameel is not itself a corporate entity, association or conglomerate run by an overarching parent company but merely refers to a group of distinct and wholly separate legal entities that are collectively referred to as Abdul Latif Jameel. Abdul Latif Jameel is not a corporate group as defined in section 1161(5) of the Companies Act 2006.

This document may contain forward-looking statements.  Forward-looking statements are statements regarding matters other than historical fact, such as future results, events, activities, developments or circumstances or the beliefs, plans or expectations of Jameel Health or Abdul Latif Jameel entities or their respective managements. Forward-looking statements often can be identified by the use of words such as ‘expect’, ‘project’, ‘anticipate’, ‘plan’, ‘estimate’, ‘believe’, ‘predict’, ‘intend’, ‘potential’, ‘possible’, ‘probable’, ‘likely’, ‘forecast’, ‘guidance’, ‘outlook’, ‘goal’, ‘target’, ‘may’, ‘will’, ‘should’ or ‘could’ or other similar terms or phrases.  However, the absence of such words does not mean that a particular statement is not forward looking. Forward-looking statements are based on expectations and assumptions at the time of such statements and are subject to numerous risks and uncertainties, many of which are outside the control of Abdul Latif Jameel Health or Abdul Latif Jameel entities.  Should any of such expectations or assumptions prove incorrect, or should any of such risks or uncertainties materialize, actual future results, events, activities, developments or circumstances may differ materially from those expressed in or implied by forward-looking statements. Further, any forward-looking statement speaks only as of the date on which it is made, and neither Abdul Latif Jameel Health nor Abdul Latif Jameel assumes, and hereby disclaims, any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.  All forward-looking statements made by Abdul Latif Jameel Health, Abdul Latif Jameel, or by any person on behalf of any of them, whether communicated in writing, electronically or orally, are qualified in their entirety by the foregoing cautionary statements. 

No Offer or Solicitation: This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.  No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or an exemption therefrom.

About Jameel Corporation: With a rich history spanning 75 years, Jameel Corporation is committed to creating value by expanding the reach of high-quality products and services across the MENAT region. The company is renowned for its strategic partnerships and extensive distribution networks.

About Yagami Co., Ltd. (Yagami): Yagami, with over 150 years of experience as a trading company for medical devices, has been actively engaged in businesses related to medical care, nursing, and public health. With 50 locations across Japan, the company has built strong relationships with 2,800 manufacturers and 3,700 medical and nursing facilities. Support goes beyond equipment sales, offering information services and participating in large-scale projects, comprehensively supporting the medical and nursing fields. Leveraging the expertise and network developed over the years, Yagami continues to take on global challenges, contributing to the health and well-being of all.